Gregory Karczmar to Neoplasms
This is a "connection" page, showing publications Gregory Karczmar has written about Neoplasms.
Connection Strength
0.505
-
Comparison of DCE-MRI of murine model cancers with a low dose and high dose of contrast agent. Phys Med. 2021 Jan; 81:31-39.
Score: 0.268
-
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol. 2012 Jul; 22(7):1451-64.
Score: 0.037
-
P-31 spectroscopy study of response of superficial human tumors to therapy. Radiology. 1991 Apr; 179(1):149-53.
Score: 0.034
-
HiSStology: high spectral and spatial resolution magnetic resonance imaging detection of vasculature validated by histology and micro-computed tomography. Mol Imaging. 2011 Jun; 10(3):187-96.
Score: 0.034
-
Response of tumors to therapy studied by 31P magnetic resonance spectroscopy. Invest Radiol. 1989 Dec; 24(12):1020-3.
Score: 0.031
-
New vanadium-based magnetic resonance imaging probes: clinical potential for early detection of cancer. J Biol Inorg Chem. 2009 Nov; 14(8):1187-97.
Score: 0.030
-
Quantitative analysis of water proton spectral lineshape: a novel source of contrast in MRI. Phys Med Biol. 2008 Sep 07; 53(17):4509-22.
Score: 0.028
-
MRI of the tumor microenvironment. J Magn Reson Imaging. 2002 Oct; 16(4):430-50.
Score: 0.019
-
Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia. 2000 Jan-Apr; 2(1-2):152-65.
Score: 0.016
-
Clinical magnetic resonance spectroscopy of brain, heart, liver, kidney, and cancer. A quantitative approach. NMR Biomed. 1989 Dec; 2(5-6):290-7.
Score: 0.008